Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Mar 31, 2026
Reporting period
Not applicable
Filed with the SEC
Apr 2, 2026
DirectorGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references dividend reinvestment
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001910621-26-000004
Filed / recorded
Apr 2, 2026, 8:16 PM UTC
Added to OQRO
Oct 2, 2026, 12:29 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
ZIMMER BIOMET HOLDINGS, INC.
Issuer CIK
1136869
Ticker
ZBH
Reporting person
Devdatt Kurdikar
Relationship
Director
Security
Phantom Stock Units
Table
Derivative (Table II)
Transaction date
Mar 31, 2026
Transaction code
A
Shares / units
154.356
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
1,928.847
Ownership form
Direct
Amendment
No
Footnotes from the filing
The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
The Conversion or Exercise Price of Derivative Security is 1-for-1.
Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.
Includes 4.508 phantom stock units accrued on January 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.